JGC
J. Goldman & Co Portfolio holdings
AUM
$2.57B
1-Year Est. Return
21.46%
This Fund
S&P 500
1 Year Est. Return
+21.46%
AUM
$2.64B
AUM Growth
-$541M
(-17%)
Holding
510
Top Buys
| 1 | +$108M | |
| 2 | +$69.6M | |
| 3 | +$65.8M | |
| 4 |
General Motors
GM
|
+$53.4M |
| 5 |
Rocket Companies
RKT
|
+$40.7M |
Top Sells
| 1 | +$129M | |
| 2 | +$79.3M | |
| 3 | +$57.7M | |
| 4 |
BellRing Brands
BRBR
|
+$43.9M |
| 5 |
TransDigm Group
TDG
|
+$41.8M |
Sector Composition
| 1 | Consumer Discretionary | 17.73% |
| 2 | Communication Services | 16.45% |
| 3 | Technology | 14.74% |
| 4 | Healthcare | 12.45% |
| 5 | Industrials | 11.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Melco Resorts & Entertainment
MLCO
$2.4B
| – | – |
0
|
|
||
502
Mueller Industries
MLI
$13.1B
| – | – |
-331,897
|
|
||
503
MoonLake Immunotherapeutics
MLTX
$1.25B
| – | – |
0
|
|
||
504
Altria Group
MO
$115B
| – | – |
-25,876
|
|
||
505
MP Materials
MP
$10.9B
| – | – |
0
|
|
||
|
MREO
506
Mereo BioPharma
MREO
$65.2M
| – | – |
-52,384
|
|
||
507
Merck
MRK
$296B
| – | – |
0
|
|
||
508
Moderna
MRNA
$19.5B
| – | – |
0
|
|
||
|
MRUS
509
DELISTED
Merus
MRUS
| – | – |
-11,816
|
|
||
510
Strategy Inc
MSTR
$44.3B
| – | – |
-1,716
|
|